These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 30519235)

  • 1. Immunization of Experimental Dogs With Salivary Proteins From
    Abbehusen MMC; Cunha J; Suarez MS; Teixeira C; Almeida VDA; Pereira LDS; Bordoni M; Gil-Santana L; Solcà MDS; Fraga DBM; Fischer L; Bozza PT; Veras PST; Valenzuela JG; Kamhawi S; Andrade BB; Brodskyn CI
    Front Immunol; 2018; 9():2558. PubMed ID: 30519235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania.
    Collin N; Gomes R; Teixeira C; Cheng L; Laughinghouse A; Ward JM; Elnaiem DE; Fischer L; Valenzuela JG; Kamhawi S
    PLoS Pathog; 2009 May; 5(5):e1000441. PubMed ID: 19461875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with LJM11 salivary protein protects against infection with Leishmania braziliensis in the presence of Lutzomyia longipalpis saliva.
    Cunha JM; Abbehusen M; Suarez M; Valenzuela J; Teixeira CR; Brodskyn CI
    Acta Trop; 2018 Jan; 177():164-170. PubMed ID: 29037520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis.
    da Silva RA; Tavares NM; Costa D; Pitombo M; Barbosa L; Fukutani K; Miranda JC; de Oliveira CI; Valenzuela JG; Barral A; Soto M; Barral-Netto M; Brodskyn C
    Acta Trop; 2011 Dec; 120(3):185-90. PubMed ID: 21875567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.
    Gomes R; Teixeira C; Teixeira MJ; Oliveira F; Menezes MJ; Silva C; de Oliveira CI; Miranda JC; Elnaiem DE; Kamhawi S; Valenzuela JG; Brodskyn CI
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7845-50. PubMed ID: 18509051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America.
    Teixeira C; Gomes R; Collin N; Reynoso D; Jochim R; Oliveira F; Seitz A; Elnaiem DE; Caldas A; de Souza AP; Brodskyn CI; de Oliveira CI; Mendonca I; Costa CH; Volf P; Barral A; Kamhawi S; Valenzuela JG
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e638. PubMed ID: 20351786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK.
    Ramiro MJ; Zárate JJ; Hanke T; Rodriguez D; Rodriguez JR; Esteban M; Lucientes J; Castillo JA; Larraga V
    Vaccine; 2003 Jun; 21(19-20):2474-84. PubMed ID: 12744881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia.
    Tavares NM; Silva RA; Costa DJ; Pitombo MA; Fukutani KF; Miranda JC; Valenzuela JG; Barral A; de Oliveira CI; Barral-Netto M; Brodskyn C
    PLoS Negl Trop Dis; 2011; 5(5):e1169. PubMed ID: 21655303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease.
    Oliveira F; Lawyer PG; Kamhawi S; Valenzuela JG
    PLoS Negl Trop Dis; 2008 Apr; 2(4):e226. PubMed ID: 18414648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.
    Aguiar-Soares RD; Roatt BM; Ker HG; Moreira Nd; Mathias FA; Cardoso JM; Gontijo NF; Bruna-Romero O; Teixeira-Carvalho A; Martins-Filho OA; Corrêa-Oliveira R; Giunchetti RC; Reis AB
    Parasit Vectors; 2014 Feb; 7():61. PubMed ID: 24507702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis.
    Costa DJ; Carvalho RM; Abbehusen M; Teixeira C; Pitombo M; Trigo J; Nascimento F; Amorim L; Abreu-Silva AL; do Socorro Pires Cruz M; Miranda JC; Fukutani K; de Oliveira CI; Barral A; Barral-Netto M; Brodskyn C
    PLoS One; 2013; 8(4):e60535. PubMed ID: 23577121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity of
    Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
    Front Immunol; 2018; 9():843. PubMed ID: 29740446
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
    Resende LA; Aguiar-Soares RD; Gama-Ker H; Roatt BM; Mendonça LZ; Alves ML; Silveira-Lemos Dd; Corrêa-Oliveira R; Martins-Filho OA; Araújo MS; Fujiwara RT; Gontijo NF; Reis AB; Giunchetti RC
    PLoS One; 2016; 11(8):e0161169. PubMed ID: 27556586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
    Ribeiro PAF; Dias DS; Lage DP; Costa LE; Martins VT; Tavares GSV; Mendonça DVC; Lima MP; Oliveira JS; Steiner BT; Machado-de-Ávila RA; Roatt BM; Chávez-Fumagalli MA; Menezes-Souza D; Duarte MC; Teixeira AL; Coelho EAF
    Cell Immunol; 2018 Sep; 331():67-77. PubMed ID: 29871740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Lutzomyia longipalpis Salivary Protein Induces Cross-Reactive Antibodies to Pemphigus Autoantigen Desmoglein 1.
    Diaz LA; Prisayanh P; Qaqish B; Temple BR; Aoki V; Hans-Filho G; Rivitti EA; Friedman H; Karetnick M; Herbert SM; Valenzuela JG;
    J Invest Dermatol; 2020 Dec; 140(12):2332-2342.e10. PubMed ID: 32360599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis.
    Zorgi NE; Arruda LV; Paladine I; Roque GAS; Araújo TF; Brocchi M; Barral M; Sanchiz Á; Requena JM; Abánades DR; Giorgio S
    Mol Immunol; 2020 Nov; 127():95-106. PubMed ID: 32949849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters.
    Pereira L; Abbehusen M; Teixeira C; Cunha J; Nascimento IP; Fukutani K; dos-Santos W; Barral A; de Oliveira CI; Barral-Netto M; Soto M; Brodskyn CI
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003490. PubMed ID: 25642946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.